Genenta Science S.p.A. Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss
Genenta Science S.p.A. (GNTA) reported Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss of EUR 103.44 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments · last filed 2026-04-01
| Period end | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|
| 2025-12-31 | 103.44K EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 70.17K EUR 6-K · filed 2025-10-10 | |
| 2024-12-31 | 96.23K EUR 20-F · filed 2025-03-28 | |
| 2024-06-30 | 125.94K EUR 6-K · filed 2024-10-29 |